Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
General Poster Session

Glucose Variability of Individuals without Diabetes Using a Long-Term Continuous Glucose Monitoring System

  1. DOROTHEE DEISS,
  2. TAHMID ABTAHI,
  3. RAVI RASTOGI and
  4. E. L. KELLEY
  1. Berlin, Germany, Germantown, MD
Diabetes 2018 Jul; 67(Supplement 1): -. https://doi.org/10.2337/db18-1542-P
Previous
  • Article
  • Info & Metrics
Loading

Abstract

Background: Prior investigations regarding glucose variability in nondiabetic subjects measured by continuous glucose monitoring (CGM) have been limited to only few weeks. Little is known about what defines healthy or pathologic glycemic variability. This study investigated “normal glycemia” under daily conditions using a long-term implantable CGM system in nondiabetic adults for 90 days.

Methods: 25 adult nondiabetic participants (10 Male, 15 Female, 17 participants >45 years old) were inserted with the Eversense® CGM System (Senseonics Inc, MD). Participants were instructed to continuously wear the CGM system during the 90 day period and calibrate the system when prompted. Analysis was performed to estimate standardized measures of euglycemia (70-180 mg/dL), hypoglycemia (<54, <70 mg/dL), hyperglycemia (>180, >200 mg/dL) and glucose variability (Mean, SD, CV).

Results: Out of 25 participants, 5 had inadequate data for inclusion. Analysis showed the average glucose value of the nondiabetic participants was 102 mg/dL (SD=18 and CV=0.17). Average percent time spent in hypoglycemia <54mg/dL was 0.14% and <70mg/dL was 1.5%. Time spent in euglycemia 70-180 mg/dL was 98%. Time spent in hyperglycemia >180 and >200 mg/dL was 0.17% and 0.05%, respectively. 17 participants had at least one value < 54mg/dL and 18 participants had glucose values >180mg/dL with 11 subjects with glucose values > 200mg/dL.

Conclusions: Glycemic variability recorded over extended period of time in participants without a diagnosis of diabetes showed similar results as observed by previous researchers over short duration with tight glycemic control. However, hypo- and hyperglycemic excursions are in some normoglycemic regarded individuals more frequent than suggested without CGM. Further analysis including meal challenge and fasting levels may provide guidance regarding expected values for persons without a diagnosis of diabetes and to set realistic target ranges for those with diabetes.

Disclosure D. Deiss: Consultant; Self; Senseonics. Advisory Panel; Self; Abbott. Consultant; Self; Roche Diabetes Care Health and Digital Solutions. Advisory Panel; Self; Becton, Dickinson and Company. T. Abtahi: Other Relationship; Self; Senseonics. R. Rastogi: Employee; Self; Senseonics. E.L. Kelley: Employee; Self; Senseonics.

  • © 2018 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Previous
Back to top
Diabetes: 67 (Supplement 1)

In this Issue

July 2018, 67(Supplement 1)
  • Table of Contents
  • Index by Author
  • Abstract PDFs
Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Glucose Variability of Individuals without Diabetes Using a Long-Term Continuous Glucose Monitoring System
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Glucose Variability of Individuals without Diabetes Using a Long-Term Continuous Glucose Monitoring System
DOROTHEE DEISS, TAHMID ABTAHI, RAVI RASTOGI, E. L. KELLEY
Diabetes Jul 2018, 67 (Supplement 1) 1542-P; DOI: 10.2337/db18-1542-P

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Glucose Variability of Individuals without Diabetes Using a Long-Term Continuous Glucose Monitoring System
DOROTHEE DEISS, TAHMID ABTAHI, RAVI RASTOGI, E. L. KELLEY
Diabetes Jul 2018, 67 (Supplement 1) 1542-P; DOI: 10.2337/db18-1542-P
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

General Poster Session

  • Effect of Restricted Caloric Intake and Bariatric Surgery on PCSK9 Concentrations in Plasma
  • The Complement-1q-Like-3 Inhibits Insulin Secretion by an Adhesion G-Protein Coupled Receptor, BAI3 in Pancreatic ß Cells
  • Impact of Mig6 on ß-Cell Regeneration and Repair
Show more General Poster Session

Epidemiology/Genetics

  • Effect of Restricted Caloric Intake and Bariatric Surgery on PCSK9 Concentrations in Plasma
  • The Complement-1q-Like-3 Inhibits Insulin Secretion by an Adhesion G-Protein Coupled Receptor, BAI3 in Pancreatic ß Cells
  • Impact of Mig6 on ß-Cell Regeneration and Repair
Show more Epidemiology/Genetics

Epidemiology–Clinical–Diagnosis and Screening

  • Association between HbA1c and Haemoglobin of Healthy Adults Visiting a Tertiary Care Hospital in India
  • Diabetes Risk in Women Employees (DRIWE)—An Institution-Based Screening Model Detects High Prevalence of Women Employees at Risk of Type 2 Diabetes
  • Comparison of Different Methods for Carbohydrate Disorder Detection
Show more Epidemiology–Clinical–Diagnosis and Screening

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.